 Leishmaniasis, Cutaneous
"Leishmaniasis, Cutaneous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.
| Descriptor ID |
D016773
|
| MeSH Number(s) |
C03.752.300.500.400 C03.858.560.400 C17.800.838.775.560.400
|
| Concept/Terms |
Oriental Sore- Oriental Sore
- Sore, Oriental
- Leishmaniasis, Old World
- Old World Leishmaniasis
|
Below are MeSH descriptors whose meaning is more general than "Leishmaniasis, Cutaneous".
Below are MeSH descriptors whose meaning is more specific than "Leishmaniasis, Cutaneous".
This graph shows the total number of publications written about "Leishmaniasis, Cutaneous" by people in UAMS Profiles by year, and whether "Leishmaniasis, Cutaneous" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 1 | 0 | 1 | | 2023 | 1 | 0 | 1 | | 2021 | 1 | 0 | 1 | | 2019 | 1 | 0 | 1 | | 2017 | 1 | 0 | 1 | | 2016 | 1 | 0 | 1 | | 2015 | 1 | 0 | 1 | | 2013 | 1 | 0 | 1 | | 2011 | 1 | 0 | 1 | | 2010 | 1 | 0 | 1 | | 2009 | 2 | 0 | 2 | | 2004 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Leishmaniasis, Cutaneous" by people in Profiles over the past ten years.
-
Nepal B, McCormick-Baw C, Patel K, Firmani S, Wetzel DM. Cutaneous Leishmania mexicana infections in the United States: defining strains through endemic human pediatric cases in northern Texas. mSphere. 2024 Mar 26; 9(3):e0081423.
-
Venugopal G, Bird JT, Roys H, Bowlin A, Fry L, Byrum SD, Weinkopff T. BOTH THE INFECTION STATUS AND INFLAMMATORY MICROENVIRONMENT INDUCE TRANSCRIPTIONAL REMODELING IN MACROPHAGES IN MURINE LEISHMANIAL LESIONS. J Parasitol. 2023 05 01; 109(3):200-210.
-
Bowlin A, Roys H, Wanjala H, Bettadapura M, Venugopal G, Surma J, Simon MC, Weinkopff T. Hypoxia-Inducible Factor Signaling in Macrophages Promotes Lymphangiogenesis in Leishmania major Infection. Infect Immun. 2021 07 15; 89(8):e0012421.
-
de Almeida M, Zheng Y, Nascimento FS, Bishop H, Cama VA, Batra D, Unoarumhi Y, Afghan AK, Shi VY, LeBoit PE, Liu EW, Donovan FM. Cutaneous Leishmaniasis Caused by an Unknown Leishmania Strain, Arizona, USA. Emerg Infect Dis. 2021 06; 27(6):1714-1717.
-
Weinkopff T, Roys H, Bowlin A, Scott P. Leishmania Infection Induces Macrophage Vascular Endothelial Growth Factor A Production in an ARNT/HIF-Dependent Manner. Infect Immun. 2019 11; 87(11).
-
Oetken T, Hiscox B, Orengo I, Rosen T. Cutaneous leishmaniasis mimicking squamous cell carcinoma. Dermatol Online J. 2017 Jan 15; 23(1).
-
Weinkopff T, Konradt C, Christian DA, Discher DE, Hunter CA, Scott P. Leishmania major Infection-Induced VEGF-A/VEGFR-2 Signaling Promotes Lymphangiogenesis That Controls Disease. J Immunol. 2016 09 01; 197(5):1823-31.
-
Huang L, Hinchman M, Mendez S. Coinjection with TLR2 agonist Pam3CSK4 reduces the pathology of leishmanization in mice. PLoS Negl Trop Dis. 2015 Mar; 9(3):e0003546.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|